【レポートの概要（一部）】
1. Report Overview
1.1 Overview of the World Market for Colorectal Cancer Drugs
1.2 Why You Should Read This Report
1.3 How This Study Delivers
1.4 Main Questions Answered by this Analysis
1.5 Who is this Report For?
1.6 Methods of Research and Analysis
1.7 Frequently Asked Questions (FAQs)
1.8 Some Associated Reports
1.9 About Visiongain
2. Introduction to Colorectal Cancer and Treatments
2.1 Pathophysiology of Colorectal Cancer
2.2 Epidemiology of Colorectal Cancer
2.2.1 Incidence – Increases with Age
2.2.2 Mortality – Fourth-Leading Cause of Cancer Death
2.2.3 Survival – Depends on Stage of Cancer
2.3 Diagnosis – Benefits and Limitations
2.4 Treatment and Staging
2.4.1 Treatment Options
2.4.2 Staging in Colorectal Cancers
2.4.3 Treatment Depending on Stages
3. The World Colorectal Cancer Drugs Market, 2015-2025
3.1 Global Colorectal Cancer Drugs Market Forecast 2015-2025
3.2 Geographical Colorectal Cancer Drugs Market Forecasts 2015-2025
3.2.1 The US Colorectal Cancer Drugs Market, 2015-2025
3.2.1.1 The US Colorectal Cancer Drugs Market Forecast – Stagnant Growth
3.2.2 The Japanese Colorectal Cancer Drugs Market, 2015-2025
3.2.2.1 The Japanese Colorectal Cancer Drugs Market Forecast – High Price of Biosimilars Will Drive the Market
3.2.3 The EU Colorectal Cancer Drugs Market, 2015-2025
3.2.3.1 The EU Colorectal Cancer Drugs Market Forecast – Tough Regulatory Environment Will Slow Market Growth
3.2.4 The APAC Countries Colorectal Cancer Drugs Market, 2015-2025
3.2.4.1 The APAC Colorectal Cancer Drugs Market Forecast – Market Will Be Stimulated by Rising Incidence of Cancer Owing to Changes of Lifestyle
3.2.5 Rest of the World Colorectal Cancer Drugs Market, 2015-2025
3.2.5.1 Rest of the World Colorectal Cancer Drugs Market Forecast
4. The Top Colorectal Cancer Drugs: Revenue Forecasts, 2015-2025
4.1 Avastin (Roche)
4.1.1 Avastin Revenue Forecast – Leader of the Pack
4.1.2 Roche
4.2 Erbitux (BMS/Merck KGaA)
4.2.1 Erbitux Revenue Forecast – Will its Revenue be Eroded by Biosimilars?
4.2.2 BMS
4.2.3 Merck KGaA
4.3 Xeloda (Roche)
4.3.1 Xeloda Revenue Forecast – Declining Sharply
4.4 Vectibix (Amgen)
4.4.1 Vectibix Revenue Forecast – Sales Will Grow During the First Half of the Forecast Period
4.4.2 Amgen
4.5 Eloxatin (Sanofi)
4.5.1 Eloxatin Revenue Forecast – Declining Slowly
4.5.2 Sanofi
4.6 Zaltrap (Sanofi/Co-developed with Regeneron)
4.6.1 Zaltrap Revenue Forecast – Sales Expected to Grow Significantly Until 2020
4.7 Stivarga (Bayer)
4.7.1 Stivarga Revenue Forecast – Positive Growth Trend
4.7.2 Bayer
4.8 TS-1 (Taiho Pharmaceuticals)
4.8.1 TS-1 Revenue Forecast
4.8.2 Taiho Pharmaceuticals
4.9 Cyramza (Eli Lilly)
4.9.1 Cyramza Revenue Forecast – Additional Approval for mCRC Will Drive Sales
4.9.2 Eli Lilly
5. Emerging Therapies
5.1 Lonsurf (Taiho Pharmaceuticals) – Approved in Japan
5.2 Sym-004 (Symphogen) – Promising Results in Early Human Clinical Trials
5.3 IMMU-130/Labetuzumab-SN-38 (Immunomedics) – ADC with High Anti-Tumour Activity
6. R&D Pipelines for Colorectal Cancer Treatment
6.1 CPX-1 (Celator Pharmaceuticals) – Combination of Irinotecan HCl and Floxuridine
6.2 CT-011/Pidilizumab (CureTech) – Binds to PD-1
6.3 Dabrafenib/Tafinlar (GSK) – Inhibitor of B-Raf
6.4 E7820 (Eisai) – Inhibits Integrin Alpha 2
6.5 Entinostat (Syndax Pharmaceuticals) – Exhibits a Wide Range of Anti-Tumour Activity
6.6 Ganetespib (Synta Pharmaceuticals) – Inhibits Hsp90
6.7 LGX818/Encorafenib (Novartis) – Investigated in Several Trials
6.8 ABT-869/Linifanib (Abbott Laboratories) – Inhibits VEGF and PDGF Receptors
6.9 MORAb-004/Ontuxizumab (Morphotek, Inc.) – Targets Endosialin
6.10 Onartuzumab (Genentech) – Targets the Protein MET
6.11 JX-594 (SillaJen) – Oncolytic Virus
6.12 PF-05212384 (Pfizer) – PI3K/mTOR Inhibitor
6.13 Simtuzumab (Gilead) – Highly Selective for LOXL2
6.14 Talaporfin Sodium (Aptocine, Light Sciences Oncology) – Water-Soluble Drug
6.15 Tivantinib (ARQ 197; ArQule, Daiichi Sankyo) – An Option for EGFR-resistant MET-High mCRC Patients
6.16 Tivozanib (Astellas Pharma/Aveo Pharmaceuticals) – Inhibits VEGF Receptors
6.17 Trametinib (Mekinist, GlaxoSmithKline) – Blocks MEK1 and MEK2
6.18 Veliparib (ABT-888, AbbVie) – An Oral PARP
6.19 RG7221/ RO5520985/Vanucizumab (Roche) – Binds Ang2 and VEGF-A
6.20BKM-120/Buparlisib (Novartis) – Reduces Cellular Levels of Phosphorylated AKT
6.21 BYL-719/Alpelisib (Novartis)
7. Qualitative Analysis of the Colorectal-Cancer Drugs Market 2015-2025
7.1 SWOT Analysis of the Colorectal Cancer Drugs Market
7.1.1 Strengths
7.1.1.1 Rising Incidence of Cancer – Ageing Population
7.1.1.2 Multiple Treatment Options Are Usually Needed
7.1.2 Weaknesses
7.1.2.1 The Challenges of Drug Development
7.1.2.2 The Complex Nature of Cancer
7.1.3 Opportunities in the Cancer Drugs Market
7.1.3.1 The Advancement of Research
7.1.3.2 A Shift Towards Personalisation
7.1.4 Threats Facing the Cancer Drugs Market
7.1.4.1 The Threat of Regulation
7.2.1 Social Factors: The Cost of Living Longer
7.2.2 Technological Developments: Making the Market Move Forward
7.2.3 Economic Pressure: Treatment’s Hefty Price Tag
7.2.4 Political Issues: Governmental Involvement in Treatment
8. Research Interviews from Our Survey – 2015
8.1 Dr. Philip M. Arlen, President and CEO, Precision Biologics, Inc., US
8.1.1 Less Than 1% of Colonoscopies Screening Reveal Cancer
8.1.2 Market Driver – New Drugs with Novel MoA and Favourable Safety Profile
8.1.3 Ensituximab – Developed From a Tumour-Derived Cancer Vaccine
8.1.4 60% of Patients with Colorectal and Pancreatic Cancer Express the Ensituximab Target
8.2 Dr. John Beadle, CEO of PsiOxus Therapeutics, UK
8.2.1 Significant Unmet Need – Effective Treatments for MSI Normal and MSI Low Patients
8.2.2 Checkpoint Inhibitors – Work Well in MSI High Patients
8.2.3 Enadenotucirev Remains Stable in Human Blood
8.2.4 Enadenotucirev – Positioning in the Colorectal Cancer Market?
9. Conclusions of the Study
9.1 Patent Expiries and the Impact of Biosimilars
9.2 The US – Still the Largest National Market
9.3 APAC – Will Show the Fastest Growth
9.4 Colorectal Cancer Drugs R&D Pipeline – Crowded, but How Many Promising Drugs?
9.5 Concluding Remarks
【レポート販売概要】
■ タイトル：大腸癌治療薬の世界市場：治療、研究開発、市場予測■ 英文：Colorectal Cancer Drugs Industry and Market: Therapies, R&D and Forecasts 2015-2025
■ 発行日：2015年11月
■ 調査会社：visiongain
■ 商品コード：VGAIN5112513
■ 調査対象地域：グローバル
- 2014年戦略提言：世界の免疫タンパク質検査市場Complete report $8,500. DataPack (test volumes, sales forecasts, supplier shares) $5,500.This new 297-page report from Venture Planning Group contains 72 tables and provides analysis of the global immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. The report pr …
- 特殊顔料のグローバル市場（2014-2018）About Specialty Pigments Specialty pigments adds color and appeal to things around us and are widely used in high-quality inks, high-performance paints and coatings, plastics, and cosmetics. The key features of specialty pigments include unique colors, high hiding efficiency, pH value, refractive index, and bulking. The performance benefits of specialty pigments are made use of by the Security Pri …
- 企業向けファイル共有・同期（EFSS）アプリケーションの世界市場予測（～2020）The Enterprise File Sharing and Synchronization market size is expected to grow from USD 1.11 Billion in 2015 to USD 3.51 Billion by 2020, at a Compound Annual Growth Rate (CAGR) of 25.7%. Composed EFSS trend, demand for cloud-based integration, and Bring-Your-Own-Device (BYOD) adoption have enabled wider adoption of EFSS solutions among many industries. Companies are increasingly adopting EFSS so …
- Dilated Cardiomyopathy：グローバル臨床試験レビューH2, 2013Dilated Cardiomyopathy Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Dilated Cardiomyopathy Global Clinical Trials Review, H2, 2013" provides data on the Dilated Cardiomyopathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dilated Cardiomyopathy. It includes an overview of the trial numbers and …
- 業務用ドリンクディスペンサーの世界市場About Commercial Beverage DispensersCommercial beverage dispensers refer to containers that keep beverages fresh for a long period of time. This equipment also allows beverages to be dispensed in prescribed amounts and is mainly used by foodservice establishments such as hotels, restaurants, catering companies, clubs, and pubs. Technavio’s analysts forecast the global commercial beverage dispenser …
- グローバル火力発電市場20142014 Global Thermal Power Market Half-Yearly Update Summary Thermal power represents the majority of global electricity generation and will continue to dominate in the future. The global thermal power market witnessed a number of developments in the first half of 2014, including contract and project announcements, fundraising activities and product launches. Most of the product launches were relat …
- Copaxone (Multiple Sclerosis)：市場予測と分析（～2022）Copaxone (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Copaxone (Multiple Sclerosis) - Forecast and Market Analysis to 2022”. Multiple sclerosis (MS) is a chronic, inflammatory neurological disorder characterized pathologically by demyelination, axonal transection and neurodegeneration within the central ner …
- Becton, Dickinson and Company：市場シェア分析Becton, Dickinson and Company Market Share Analysis Summary GlobalData’s new report, “Becton, Dickinson and Company Market Share Analysis” provides in-depth information on Becton, Dickinson and Company s market position in the different medical equipment markets it operates in. The report provides Becton, Dickinson and Company market share information in eight key market categories – Histology And …
- PT Medco Energi Internasional Tbk：石油・ガスバリューチェーン分析レポート2013PT Medco Energi Internasional Tbk Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "PT Medco Energi Internasional Tbk" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “PT Medco Energi Internasional Tbk”. The report provides key information relating to oil and gas assets of the company along with its operations …
- Novoseven RT (Hemophilia A and B)：市場予測と分析（～2022）Novoseven RT (Hemophilia A and B) - Forecast and Market Analysis to 2022 Summary The competitive landscape of hemophilia A and B recombinant therapy in the US and 5EU is dominated by the use of recombinant FVIII and FIX replacement factors, and patients with severe forms of the disease receive frequent prophylactic infusions beginning from the first one or two years of life and often continuing th …
- 欧州の風力発電産業分析：Analyzing the European Wind Power IndustryAs demand on finite petroleum reserves and the price of the fuels derived from them continues to rise, renewable forms of energy are becoming more cost-effective and profitable. In the forefront of this renewable revolution is harnessing the sustainable power of wind. Today it is one of the most positive developments created by the present storm of uncertainty unleashed as a result of escalating o …
- Humira（クローン病治療薬）：市場予測及び分析（～2022）Humira (Crohn’s Disease) - Forecast and Market Analysis to 2022 Summary The Crohn’s disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will challenge the current biologics in an attempt to dislodge the stronghold of the TNF inhibitors, as they aim to tap into the lucrative portion of the CD therapeutics market. If their promising safety and …
- ビックデータ分野のリーディング企業分析：オラクルBig Data represents a collection of data sets so large and complex that it becomes difficult to process using on-hand database management tool. It is also unstructured, meaning that it is not tabulated, correlated, etc. (e.g. it does not have a pre-defined data model or is not organized in a pre-defined manner). Big Data technologies enable organizations to handle huge datasets and generate inform …
- クロマトグラフィー樹脂の世界市場予測（～2021年）MarketsandMarkets projects that the market for chromatography resin will grow from USD 1.72 Billion in 2016 to USD 2.46 Billion by 2021, at a CAGR of 7.41% from 2016 to 2021. The chromatography resin market is expected to grow during the forecast period, because of rising demand from pharmaceutical & biotechnology, food & beverage, and water & environmental analysis applications. The chromatograph …
- グローバルモバイルセキュリティ市場（2014 – 2020）：端末、インフラ、サービスMobile networks around the globe generate more than 86 Exabytes of traffic annually. The immense volume of traffic together with the growing adoption of open source Operating System (OS) platforms such as Android has opened up new security threats. Mobile malware, SMS spam, cyber attacks and unlawful eavesdropping are an ever-increasing problem for enterprises, consumers and mobile network operato …
